Trials / Active Not Recruiting
Active Not RecruitingNCT04965792
Post-treatment Surveillance in HPV+ Oropharyngeal SCC
Circulating HPV DNA for Post-treatment Surveillance in HPV-positive Oropharyngeal Squamous Cell Carcinoma
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Dana-Farber Cancer Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
In this research study the investigators are examining a blood test to detect HPV DNA in the blood that can possibly detect cancer recurrence earlier than with standard surveillance measures.
Detailed description
This research study involves blood tests to detect HPV DNA at regular time points after treatment for HPV-positive oropharyngeal squamous cell carcinoma (HPV-OPC). Participants may undergo scans based on the results of the blood tests. Study participants will also be asked to complete quality of life questionnaires periodically. Participation in this study may last for up to 3 years. It is expected that about 150 people will take part in this research study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Screening | Blood test |
Timeline
- Start date
- 2020-11-19
- Primary completion
- 2026-11-01
- Completion
- 2027-11-01
- First posted
- 2021-07-16
- Last updated
- 2025-06-17
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04965792. Inclusion in this directory is not an endorsement.